| Literature DB >> 28553620 |
Muhammad A Rasheed1,2,3, Jingjing Qi1,4, Xifang Zhu1,2, He Chenfei1,2, Harish Menghwar1,2, Farhan A Khan1,2, Gang Zhao1,2, Muhammad Zubair1,2, Changmin Hu2, Yingyu Chen2, Huanchun Chen1,2,5,6, Aizhen Guo1,2,5,6.
Abstract
Mycoplasma bovis is an important cause of bovine respiratory disease worldwide. To understand its virulence mechanisms, we sequenced three attenuated M. bovis strains, P115, P150, and P180, which were passaged in vitro 115, 150, and 180 times, respectively, and exhibited progressively decreasing virulence. Comparative genomics was performed among the wild-type M. bovis HB0801 (P1) strain and the P115, P150, and P180 strains, and one 14.2-kb deleted region covering 14 genes was detected in the passaged strains. Additionally, 46 non-sense single-nucleotide polymorphisms and indels were detected, which confirmed that more passages result in more mutations. A subsequent collective bioinformatics analysis of paralogs, metabolic pathways, protein-protein interactions, secretory proteins, functionally conserved domains, and virulence-related factors identified 11 genes that likely contributed to the increased attenuation in the passaged strains. These genes encode ascorbate-specific phosphotransferase system enzyme IIB and IIA components, enolase, L-lactate dehydrogenase, pyruvate kinase, glycerol, and multiple sugar ATP-binding cassette transporters, ATP binding proteins, NADH dehydrogenase, phosphate acetyltransferase, transketolase, and a variable surface protein. Fifteen genes were shown to be enriched in 15 metabolic pathways, and they included the aforementioned genes encoding pyruvate kinase, transketolase, enolase, and L-lactate dehydrogenase. Hydrogen peroxide (H2O2) production in M. bovis strains representing seven passages from P1 to P180 decreased progressively with increasing numbers of passages and increased attenuation. However, eight mutants specific to eight individual genes within the 14.2-kb deleted region did not exhibit altered H2O2 production. These results enrich the M. bovis genomics database, and they increase our understanding of the mechanisms underlying M. bovis virulence.Entities:
Keywords: Mycoplasma bovis; attenuation; bioinformatics; genome; virulence
Mesh:
Substances:
Year: 2017 PMID: 28553620 PMCID: PMC5426083 DOI: 10.3389/fcimb.2017.00177
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
The 14 genes present in the 14.2-kb deleted region of the three attenuated strains.
| 854,329 | 854,446 | Ascorbate-specific PTS system enzyme IIB component | |
| 854,545 | 856,353 | Ascorbate-specific PTS system enzyme IIA component | |
| 856,405 | 857,466 | Phosphotriesterase family protein | |
| 857,812 | 858,669 | Predicted hydrolases of the HAD superfamily | |
| 858,857 | 859,093 | Hypothetical protein | |
| 859,172 | 860,956 | DNA methyltransferase | |
| 861,333 | 861,512 | Amino-terminal fragment of hypothetical protein; pseudo | |
| 861,695 | 862,609 | Putative lipoprotein | |
| 862,734 | 863,949 | Lipoprotein containing a frameshift mutation; pseudo | |
| 864,069 | 865,058 | Putative lipoprotein | |
| 865,436 | 865,627 | Hypothetical protein | |
| 865,790 | 866,689 | Conserved hypothetical protein | |
| 866,753 | 868,621 | Type III RM system methylase; pseudo | |
| 865220 | 865,383 | Putative lipoprotein |
SNPs and indels in the three attenuated strains, compared with strain HB0801, after resequencing and PCR confirmation.
| 1 | C-A | C-A | C-A | S17,328 | Simple sugar ABC transporter ATP-binding protein | |
| 2 | C-A | C-A | C-A | S151,187 | Spermidine/putrescine ABC transporter ATP-binding protein | |
| 3 | C-T | C-T | C-T | S183,285 | D-lactate dehydrogenase | |
| 4 | C-T | C-T | C-T | S241,786 | Ribose-phosphate pyrophosphokinase | |
| 5 | C-A | C-A | C-A | S418,864 | Putative lipoprotein | |
| 6 | T-C | T-C | T-C | S562,835 | Enolase | |
| 7 | G-A | G-A | G-A | S562,695 | Enolase | |
| 8 | C-T | C-T | C-T | S609,729 | Putative lipoprotein | |
| 9 | C-T | C-T | C-T | S628,787 | Cation transporting ATPase | |
| 10 | C-A | C-A | C-A | S669,593 | Phosphate acetyltransferase | |
| 11 | C-A | C-A | C-A | S691,444 | Putative transmembrane protein | |
| 12 | C-A | C-A | C-A | S742,189 | Large-conductance mechanosensitive ion channel | |
| 13 | C-A | C-A | C-A | S848,007 | Predicted integral membrane protein | |
| 14 | G-C | G-C | G-C | S901,268 | Conserved hypothetical protein | |
| 15 | – | C-T | C-T | S175,797 | Pyruvate kinase | |
| 16 | – | C-T | C-T | S187,262 | Hypothetical protein | |
| 17 | – | C-T | C-T | S618,377 | Phosphopentomutase | |
| 18 | – | A-T | A-T | S684,890 | Membrane lipoprotein P81 | |
| 19 | – | G-A | G-A | S743,651 | Heat shock protein GrpE | |
| 20 | – | C-A | C-A | S845,529 | Predicted integral membrane protein | |
| 21 | – | G-A | G-A | S929,799 | VspHB0801-5 | |
| 22 | – | A-C | A-C | S964,804 | Thioredoxin | |
| 23 | – | G-A | – | S58,153 | Putative lipoprotein | |
| 24 | C-T | – | – | S120,789 | Putative lipoprotein | |
| 25 | C-T | – | – | S247,443 | Transketolase | |
| 26 | G-T | – | – | S284,709 | Integrase | |
| 27 | – | – | G-A | S350,175 | NADH dehydrogenase | |
| 28 | – | – | C-A | S388,007 | Exopolyphosphatase-related protein | |
| 29 | C-A | – | – | S457,329 | Putative membrane lipoprotein (ICEB-1 encoded) | |
| 30 | C-T | – | – | S472,982 | Transcription elongation factor | |
| 31 | – | – | G-A | S638,676 | Putative transmembrane protein | |
| 32 | – | – | C-A | S628,101 | Cation transporting ATPase | |
| 33 | – | – | C-T | S667,404 | L-lactate dehydrogenase | |
| 34 | – | – | G-A | S833,489 | Transcriptional accessory protein | |
| 35 | – | – | T-C | S871,124 | Putative transmembrane protein | |
| 36 | – | – | G-A | S876,089 | Glycerol ABC transporter ATP binding component | |
| 37 | – | – | G-A | S950,221 | Hypothetical protein | |
| 38 | – | T-C | – | S957,308 | Peptide chain release factor | |
| 1 | – | Del A | Del A | D399,903 | Alcohol dehydrogenase | |
| 2 | – | Del CTAGT | Del CTAGT | D402,407 | Putative transmembrane protein | |
| 3 | – | Del CT | Del CT | D414,907 | Putative lipoprotein | |
| 4 | Del C | – | Del C | D423,697 | Pseudogene of cytosine-specific methyltransferase | |
| 5 | – | Del G | Del G | D620,722 | Putative membrane lipoprotein | |
| 6 | – | – | Del A | D687,694 | Multiple sugar ABC transporter ATP-binding protein | |
| 7 | Del G | Del G | Del G | D768,061 | Putative lipoprotein (variable) | |
| 8 | – | Del CT | Del CT | D798,998 | Putative lipoprotein |
S, SNP; Del, deletion. The data are categorized into four categories. 1, SNP present in all three passages; 2, SNP present in two passages; 3, SNP present in one passage; 4, deletions found in the genes.
Figure 1Genomic comparison of Genome structures of the M. bovis HB0801 strain and the three attenuated strains; (B) Serial propagation of HB0801 resulted in the deletion of a 14.2-kb fragment in the genome of the three attenuated strains. The red lines show the lengths of the genomes of respective strains. The lengths of the P115, P150, and P180 strains are reduced and shown in dashes at the ends of the lines.
Figure 2Protein–protein interaction map of the available proteins from the list of analyzed proteins from Tables . Different colored lines show different types of interactions. Hence, more lines show more interactions and an increased probability of a protein–protein interaction. The image and related details were retrieved from the STRING database (http://www.string-db.org/). (A) Evidence view; (B) Interactive view. In evidence view, all possible interactions are shown. Different colored lines show different types of interactions e.g., gene fusion, co-occurrence, co-expression, experiments, databases, text mining etc. While in interactive view, the interactive proteins are clustered together based on interaction and co-occurrence.
Figure 3The mutated genes from Tables . Fifteen genes were shown to be enriched in 15 metabolic pathways. Ten of the fifteen genes are involved in more than one pathway.
Putative secretory proteins with signal peptides.
| Putative lipoprotein | 0.638 | 0.724 | 0.556 | 33 | |
| Putative lipoprotein | 0.498 | 0.716 | 0.181 | 26 | |
| Putative lipoprotein | 0.623 | 0.798 | 0.363 | 32 | |
| Putative lipoprotein | 0.566 | 0.845 | 0.184 | 32 | |
| Putative membrane lipoprotein (ICEB-1 encoded) | 0.465 | 0.68 | 0.185 | 24 | |
| Putative lipoprotein | 0.551 | 0.88 | 0.176 | 32 | |
| Putative membrane lipoprotein | 0.693 | 0.893 | 0.344 | 23 | |
| Membrane lipoprotein P81 | 0.591 | 0.884 | 0.184 | 25 | |
| Putative lipoprotein | 0.722 | 0.853 | 0.533 | 32 | |
| Putative lipoprotein | 0.568 | 0.792 | 0.206 | 25 | |
| VspHB0801-5 | 0.659 | 0.946 | 0.238 | 23 | |
| Putative lipoprotein | 0.641 | 0.918 | 0.229 | 25 |
Secretory proteins with signal peptides were identified by Pred-lipo (.
Conserved domains in the secretory proteins.
| Putative lipoprotein | 330–636 | SMC_prok_A | |
| Putative lipoprotein | 29–176 | PLN02967 | |
| Putative lipoprotein | 304–660 | DUF31 | |
| Putative lipoprotein | 392–764 | DUF31 | |
| Membrane lipoprotein P81 | 257–482 & 570–698 | Lipoprotein_X & Lipoprotein_10 | |
| Putative lipoprotein | 6–175, 183–253 | PRK08581, rad23 | |
| Putative lipoprotein | 189–286 | Peptidase C19 | |
| VspHB0801-5 | 46–74, 70–98, 195–253, 152–180 | DUF1388, DUF1388, CDC45, DUF1388 |
The analysis highlights the presence of conserved domains in the secretory proteins. The analysis was performed using the NCBI server (.
Virulence-related factor identification in .
| IS1634AV transposase [ | 1,060 | 0 | |
| elongation factor Tu [ | 754 | 0 | |
| predicted lipoprotein [monocytic differentiation factor] [ | 743 | 0 | |
| hypothetical protein [Mg2+ transport] [ | 657 | 0 | |
| P48, predicted lipoprotein [ | 627 | 1.00E-180 | |
| pyruvate dehydrogenase E1 component [ | 611 | 1.00E-175 | |
| endopeptidase Clp ATP-binding chain C [ | 546 | 1.00E-155 | |
| molecular chaperone DnaK [ | 475 | 1.00E-134 | |
| phosphopyruvate hydratase [ | 443 | 1.00E-124 | |
| oligopeptide ABC transporter [ | 414 | 1.00E-116 | |
| glyceraldehyde 3-phosphate dehydrogenase [ | 404 | 1.00E-113 | |
| SecA DEAD domain protein [ | 392 | 1.00E-109 | |
| NAD dependent DNA ligase [ | 332 | 3.00E-91 | |
| PgPepO oligopeptidase [ | 280 | 3.00E-75 | |
| peptide methionine sulfoxide reductase [ | 280 | 8.00E-76 | |
| lipid A ABC exporter [ | 273 | 2.00E-73 | |
| RNA polymerase, RpoD family [ | 236 | 3.00E-62 | |
| lipid A export ATP-binding protein MsbA [ | 234 | 1.00E-61 | |
| lipoyltransferase and lipoate-protein ligase family protein [ | 231 | 3.00E-61 | |
| putative lipase protein ligase A [ | 226 | 1.00E-59 | |
| hypothetical protein [ | 225 | 4.00E-59 | |
| magnesium-translocating P-type ATPase [ | 222 | 7.00E-58 | |
| predicted lipoprotein [ | 207 | 6.00E-54 | |
| P65 lipoprotein-like protein [ | 201 | 7.00E-51 | |
| probable phosphomannomutase [ | 199 | 5.00E-51 | |
| glucose-1-phosphate uridylyltransferase [ | 197 | 5.00E-51 | |
| lipid transporter ATP-binding/permease [ | 187 | 2.00E-47 | |
| adenosine synthase A [ | 177 | 1.00E-44 | |
| membrane nuclease [ | 173 | 2.00E-43 | |
| variable surface lipoprotein W [ | 168 | 3.00E-42 | |
| type III secretion system ATPase [ | 160 | 2.00E-39 | |
| variable surface lipoprotein V [ | 160 | 8.00E-40 | |
| fused lipid transporter subunits of ABC superfamily [ | 159 | 4.00E-39 | |
| ABC transporter ATP-binding protein [ | 157 | 2.00E-38 | |
| P65 lipoprotein-like protein [ | 154 | 9.00E-37 | |
| type III secretion system ATPase [ | 153 | 3.00E-37 | |
| (CbuG_0446) hypothetical protein [type IV secretion system effector] [ | 153 | 8.00E-38 | |
| oligopeptide ABC transporter [ | 150 | 4.00E-36 | |
| alcohol dehydrogenase [MymA operon] [ | 140 | 2.00E-33 | |
| zinc-type alcohol dehydrogenase [ | 134 | 1.00E-31 | |
| flagellum-specific ATP synthase FliI [ | 131 | 1.00E-30 | |
| predicted cytoskeletal protein [ | 124 | 1.00E-27 | |
| maltodextrin import ATP-binding protein [ | 122 | 4.00E-28 | |
| trigger factor [ | 120 | 2.00E-27 | |
| hemolysin secretion protein HlyB [ | 120 | 8.00E-28 | |
| sugar ABC transporter ATP-binding protein [ | 117 | 1.00E-26 | |
| oligopeptide ABC transporter [ | 113 | 3.00E-25 | |
| phthiocerol dimycocerosate and phenolic glycolipid biosynthesis and transport [ | 110 | 9.00E-25 | |
| HrcN [type III secretion system] [ | 106 | 4.00E-23 | |
| HitC iron(III) ABC transporter ATP-binding protein [ | 104 | 1.00E-22 | |
| lipoprotein diacylglyceryl transferase [ | 103 | 1.00E-22 | |
| serine/threonine protein kinase [ | 102 | 1.00E-27 | |
| fibronectin-binding protein [ | 100 | 5.00E-21 | |
| segregation and condensation protein B [ | 100 | 5.00E-22 | |
| ABC transporter, ATP-binding protein [ | 99 | 3E-21 | |
| iron ABC transporter ATP-binding protein [ | 96 | 3.00E-20 | |
| iron-uptake permeate ATP-binding protein [ | 93 | 4.00E-19 | |
| lipopolysaccharide core biosynthesis protein [ | 92 | 8.00E-20 | |
| oligopeptide ABC transporter [ | 89 | 6.00E-18 | |
| ABC-type transporter [ | 89 | 9.00E-18 | |
| Putative short-chain type dehydrogenase/reductase [ | 89 | 3.00E-18 | |
| LicA protein [LOS] [ | 89 | 3.00E-18 | |
| AdhD alcohol dehydrogenase [ | 88 | 7.00E-18 | |
| HlyC/CorC family [hemolysin] [ | 87 | 3.00E-17 | |
| protein phosphatase PrpC [ | 86 | 2.00E-17 | |
| beta-1,3 galactosyltransferase [ | 85 | 6.00E-17 | |
| elongation factor Tu [EF-Tu] [ | 84 | 3.00E-16 | |
| Dot/Icm type IV secretion system effector [ | 83 | 1.00E-16 | |
| variable surface lipoprotein W (VpmaW precursor) [ | 82 | 6.00E-16 | |
| variable surface lipoprotein Y [ | 80 | 2.00E-15 | |
| iron-dicitrate transporter ATP-binding subunit [ | 80 | 1.00E-15 | |
| ATPase [Proteasome-associated proteins] [ | 80 | 4.00E-15 |
Virulence proteins found in the VDFB for M. bovis HB0801 proteins using BLAST are listed as a VFDB hit. Scores and E-values were generated by the BLAST algorithm. The data were filtered by BLAST scores ≥ 80.
Figure 4Production of H. Significant differences between groups are highlighted with asterisks. (A) Comparison of the wild-type M. bovis HB0801 strain and strains that were subjected to different numbers of passages during in vitro growth. (B) Comparison of the wild-type M. bovis HB0801 with different transposon-disrupted mutants during in vitro growth. These transposon-disrupted mutants were produced using the virulent M. bovis HB0801 and a Tn4001 transposon. Gene numbers of M. bovis given are as follows. 0723 = Mbov_0723, 0724 = Mbov_0724, 0725 = Mbov_0725, 0727 = Mbov_0727, 0730 = Mbov_0730, 0732 = Mbov_0732, 0734 = Mbov_0734, and 0735 = Mbov_0735.
Figure 5Schematic illustration of H. Glycerol is transported into the cell by the GlpF membrane transporter. Glycerol is phosphorylated to glycerol-3-P by GlpK (glycerol kinase). Moreover, glycerol-3-phosphate is also recycled through ABC transporters (UgpA, C, and E). Glycerol-3-phosphate is converted to dihydroxyacetone phosphate (DHAP) by oxidoreductase GlpO. H2O2 is secreted during and after the whole process. Mutations in the genes of mycoplasmas related to these metabolic pathways lead to decreased H2O2 production. CM, cell membrane. The sign shows the mutations in the pathways, and mutated genes are listed with this sign.